BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21971458)

  • 1. The merits of FDDNP-PET imaging in Alzheimer's disease.
    Shin J; Kepe V; Barrio JR; Small GW
    J Alzheimers Dis; 2011; 26 Suppl 3():135-45. PubMed ID: 21971458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.
    Shin J; Lee SY; Kim SH; Kim YB; Cho SJ
    Neuroimage; 2008 Nov; 43(2):236-44. PubMed ID: 18694837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-(1-{6-[(2-[fluorine-18]fluoroethyl)(methyl) amino]-2-naphthyl} ethylidene)malononitrile (FDDNP) positron emission tomography patterns in nondemented populations.
    Shin J; Lee SY
    Am J Geriatr Psychiatry; 2010 Feb; 18(2):187; author reply 188. PubMed ID: 20104075
    [No Abstract]   [Full Text] [Related]  

  • 6. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease.
    Braskie MN; Klunder AD; Hayashi KM; Protas H; Kepe V; Miller KJ; Huang SC; Barrio JR; Ercoli LM; Siddarth P; Satyamurthy N; Liu J; Toga AW; Bookheimer SY; Small GW; Thompson PM
    Neurobiol Aging; 2010 Oct; 31(10):1669-78. PubMed ID: 19004525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.
    Shoghi-Jadid K; Small GW; Agdeppa ED; Kepe V; Ercoli LM; Siddarth P; Read S; Satyamurthy N; Petric A; Huang SC; Barrio JR
    Am J Geriatr Psychiatry; 2002; 10(1):24-35. PubMed ID: 11790632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment.
    Barrio JR; Kepe V; Satyamurthy N; Huang SC; Small G
    J Nutr Health Aging; 2008 Jan; 12(1):61S-5S. PubMed ID: 18165848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.
    Small GW; Siddarth P; Burggren AC; Kepe V; Ercoli LM; Miller KJ; Lavretsky H; Thompson PM; Cole GM; Huang SC; Phelps ME; Bookheimer SY; Barrio JR
    Arch Gen Psychiatry; 2009 Jan; 66(1):81-7. PubMed ID: 19124691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
    Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
    Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.
    Thompson PW; Ye L; Morgenstern JL; Sue L; Beach TG; Judd DJ; Shipley NJ; Libri V; Lockhart A
    J Neurochem; 2009 Apr; 109(2):623-30. PubMed ID: 19226369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.
    Lavretsky H; Siddarth P; Kepe V; Ercoli LM; Miller KJ; Burggren AC; Bookheimer SY; Huang SC; Barrio JR; Small GW
    Am J Geriatr Psychiatry; 2009 Jun; 17(6):493-502. PubMed ID: 19472439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.
    Kepe V; Huang SC; Small GW; Satyamurthy N; Barrio JR
    Methods Enzymol; 2006; 412():144-60. PubMed ID: 17046657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl)amino]-2-naphthyl]ethylidene)malononitrile.
    Agdeppa ED; Kepe V; Petri A; Satyamurthy N; Liu J; Huang SC; Small GW; Cole GM; Barrio JR
    Neuroscience; 2003; 117(3):723-30. PubMed ID: 12617976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.
    Agdeppa ED; Kepe V; Liu J; Flores-Torres S; Satyamurthy N; Petric A; Cole GM; Small GW; Huang SC; Barrio JR
    J Neurosci; 2001 Dec; 21(24):RC189. PubMed ID: 11734604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological well-being and regional brain amyloid and tau in mild cognitive impairment.
    Chen ST; Siddarth P; Saito NY; Rueda F; Haight T; Ercoli LM; Miller KJ; Lavretsky H; Barrio JR; Bookheimer SY; Small GW; Merrill DA
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):362-9. PubMed ID: 23567426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.
    Wardak M; Wong KP; Shao W; Dahlbom M; Kepe V; Satyamurthy N; Small GW; Barrio JR; Huang SC
    J Nucl Med; 2010 Feb; 51(2):210-8. PubMed ID: 20080894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: novel PET/SPECT imaging probes for diagnosis of Alzheimer's disease.
    Ono M; Saji H
    J Pharmacol Sci; 2012; 118(3):338-44. PubMed ID: 22382657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential FDDNP PET patterns in nondemented middle-aged and older adults.
    Ercoli LM; Siddarth P; Kepe V; Miller KJ; Huang SC; Cole GM; Lavretsky H; Bookheimer SY; Kim J; Phelps ME; Barrio JR; Small GW
    Am J Geriatr Psychiatry; 2009 May; 17(5):397-406. PubMed ID: 19390297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seeing is believing: neuroimaging adds to our understanding of cerebral pathology.
    Small GW; Kepe V; Barrio JR
    Curr Opin Psychiatry; 2006 Nov; 19(6):564-9. PubMed ID: 17012932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.